Clinical–epidemiological characteristics and survival time of deceased COVID-19 patients treated at hospitals belonging to Red Sabogal–Callao in 2020
DOI:
https://doi.org/10.24265/horizmed.2020.v20n2.03Keywords:
Coronavirus, Coronavirus infections, Epidemiology, MortalityAbstract
Objective: To describe the clinical–epidemiological characteristics and the survival time of deceased COVID-19 patients treated at hospitals belonging to Red Sabogal–Callao in 2020. Materials and methods: An observational, descriptive and retrospective study conducted in a population of 23 patients who died of COVID-19 from the beginning of the state of emergency (March 11, 2020) to April 15 at two hospitals belonging to Red Sabogal–Callao. The data was analyzed using the Stata Statistical Software: Release 16. The survival time was assessed by means of the Kaplan-Meier survival analysis and the log-rank test, with a 95 % confidence interval. Results: The predominant epidemiological characteristics were male sex, 60 to 79 years of age and comorbidities (hypertension and obesity). The main signs and symptoms at hospital admission were dyspnea, fever, cough and increased respiratory rate. Laboratory tests showed abnormal values: PaO₂/FiO₂ ratio < 300, leukocytosis, lymphopenia and increased lactate levels. Ground-glass opacities with bilateral pulmonary involvement prevailed in the radiological reports. During the hospital stay, 60.87 % of the patients were treated in the Intensive Care Unit (ICU), 69.57 % were on mechanical ventilation, 39.13 % received a therapeutic scheme consisting of hydroxychloroquine plus azithromycin, and 39.13 % received corticosteroids additionally to the aforementioned treatment. The patients died before reaching 20 days of hospital stay; on day five, the general survival probability was 43.48 %; and the survival probability was higher, although without statistical significance (p = 0.17), in those on mechanical ventilation. Conclusions: Deceased patients were mainly males, older adults, those with underlying health conditions such as hypertension and obesity, and those classified as having moderate to severe COVID-19 infection at hospital admission. The longest survival time was observed among those on mechanical ventilation.
Downloads
References
Organización Mundial de la Salud. COVID-19: cronología de la actuación de la OMS [Internet]. 2020. Disponible en: https://www.who.int/es/news-room/detail/08-04-2020-who-timeline--covid-19
Organización Mundial de la Salud. Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020 [Internet]. 2020. Disponible en: https://www.who.int/es/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefingon-covid-19---11-march-2020
Instituto Nacional de Salud. Ministra Hinostroza pidió tener confianza en el Sistema de Salud tras confirmarse primer caso de coronavirus en Perú [Internet]. 2020. Disponible en: http://web. ins.gob.pe/es/prensa/noticia/ministra-hinostroza-pidio-tenerconfianza-en-el-sistema-de-salud-tras-confirmarse
Andina Difusión. Ministerio de Salud confirma primera muerte por COVID-19 en Perú [Internet]. Agencia Peruana de Noticias Andina. 2020. Disponible en: https://andina.pe/agencia/noticia-ministerio-salud-confirma-primera-muerte-coronavirusperu-789125.aspx
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395(10223): 507-13.
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020.
Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J, et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020; 41(0): E006.
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020.
Al-Hameed FM. Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus. Saudi Med J. 2017; 38(2): 196-200.
Ministerio de Salud. Prevención y atención de personas afectadas por COVID-19 en el Perú [Internet]. 2020. Disponible en: https:// cdn.www.gob.pe/uploads/document/file/574295/resolucionministerial-139-2020-MINSA.PDF
Organización Panamericana de Salud, Organización Mundial de la Salud. Actualización Epidemiológica. Nuevo coronavirus (COVID-19) [Internet]. 2020. Disponible en: https://www.paho.org/sites/default/files/2020-02/2020-feb-14-phe-actualizacionepi-covid19.pdf
Centers for Disease Control and Prevention. Real-Time (RT-PCR) panel for detection 2019-nCoV [Internet]. 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detectioninstructions.html
Instituto Nacional de Salud. Uso de pruebas rápidas para COVID-19 [Internet]. Ministerio de Salud; 2020. Disponible en: https://web.ins.gob.pe/sites/default/files/Archivos/cnsp/coronavirus/prueba_ rapida/PRUEBAS%20RAPIDAS%20COVID-19%20(REV.%20GOB.).pdf
Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE. 2020; 15(3): e0230548.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497-506.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395(10229): 1054-62.
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 1-3.
Ministerio de Salud. COVID-19 en el Perú [Internet]. 2020. Disponible en: https://covid19.minsa.gob.pe/sala_situacional.asp
Escobar G, Taype W, Ayala R, Arnado J. Características clínicoepidemiológicas de pacientes fallecidos por COVID-19 en un hospital nacional de Lima, Perú. Rev Fac Med Hum. 2020; 20(2): 180-5.
Presidencia de la República. Decreto Supremo que declara en Emergencia Sanitaria a nivel nacional por el plazo de noventa (90) días calendario y dicta medidas de prevención y control del COVID-19. Diario Oficial del Bicentenario “El Peruano”. 2020. Disponible en: https://busquedas.elperuano.pe/normaslegales/decreto-supremo-que-declara-en-emergencia-sanitaria-a-niveldecreto-supremo-n-008-2020-sa-1863981-2/
Rebasa P. Conceptos básicos del análisis de supervivencia. Cir Esp. 2005; 78(4): 222-30.
Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; S1198743X(20): 30217-2.
Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Heide RSV. Pulmonary and cardiac pathology in COVID-19: the first autopsy series from New Orleans. medRxiv. 2020.
Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect. 2020; S01634453(20): 30191-2.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).